Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacology and Toxicology Studies
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Breast tumor exosomal Jak3BP mediated immunosuppression
TUSM/T-NEMC CENTER FOR NEUROSCIENCE RESEARCH - behavior core
Humanized Anti Tac Antibody Therapy in Leukemia/ Lymphom
Bioorganic Chemistry of Antibacterials
Regulation of Intracellular Peptide Hormone Receptors
Recently added grants:
Physical Activity in Underserved Populations: Using Epidemiologic Assessments to Inform Sustainable Intervention
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
Control of B cell differentiation by IFNg induced transcription factors
Effect of Microbial Metabolites on Growth of Cryptosporidium
Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43306-5-0-1
Application #
7575413
Study Section
Project Start
2004-06-30
Project End
2009-06-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacology and Toxicology Studies
/ University of Illinois at Chicago
$1,278,125
NIH 2007
N01 CA
Preclinical Pharmacology and Toxicology Studies
Lyubimov, Alex /
$1,310,660
NIH 2007
N01 CA
Preclinical Pharmacology and Toxicology Studies
/
Comments
Be the first to comment on this grant